Pulmonology Lasers Market Size & Trends, Growth
The Global Pulmonology Lasers Market has witnessed continuous growth in the last few years and is projected to grow even further during the forecast period of 2024-2033. The assessment provides a 360° view and insights - outlining the key outcomes of the Pulmonology Lasers market, current scenario analysis that highlights slowdown aims to provide unique strategies and solutions following and benchmarking key players strategies. In addition, the study helps with competition insights of emerging players in understanding the companies more precisely to make better informed decisions.
Browse for Full Report at @ https://www.thebrainyinsights.com/report/pulmonology-lasers-market-13243
📌 Recent Developments
Boston Scientific acquired Lumenis’s surgical laser business (including pulmonology portfolio) in September 2021, integrating advanced MOSES laser tech into its offerings .
Lumibird Medical (France) launched the Capsulo Nd:YAG laser in September 2022—an integrated device enhancing precision and safety in treatment
🚀 Drivers
Rising global burden of chronic respiratory diseases (COPD, asthma, lung cancer) increases demand for minimally invasive pulmonary interventions using laser therapy .
Technological advancement: miniaturized devices, precision laser delivery, integration with imaging and software tools drive clinical adoption
Growing patient and provider preference for minimally invasive procedures—shorter recovery, less trauma—boosts adoption
⛔ Restraints
High capital and maintenance costs of pulmonology lasers deter use, especially in developing regions without sufficient reimbursement policies .
Limited awareness of laser-based pulmonology treatments in emerging markets reduces adoption .
🌍 Regional Segmentation Analysis
North America leads the market (over 40% share), driven by advanced infrastructure, R&D investment, and broad clinical adoption
Europe follows, benefiting from increased healthcare expenditure and supportive policies .
Asia‑Pacific is the fastest‑growing region due to rapidly rising respiratory disease prevalence, expanding healthcare infrastructure, and increased funding .
Latin America and Middle East & Africa show smaller but steady growth, constrained by infrastructure and reimbursement barriers .
🌱 Emerging Trends
Next‑generation integrated lasers combining hardware and advanced software for improved diagnostics and therapeutic precision
Adoption of precision medicine approaches, focusing on patient-specific laser treatment protocols .
Combining lasers with immunotherapies or other treatments, and emphasis on cost-accessibility frameworks and ethical/regulatory oversight .
🔧 Top Use Cases
Bronchial tumor ablation, especially in early-stage lung cancer
Airway management: treating stenosis, hemorrhage, benign neoplasms, tracheal lesions via bronchoscopy with laser tools
Diagnostic bronchoscopy guided by laser visualization and photodynamic aid.
⚠️ Major Challenges
Reimbursement limitations, especially in developing regions, creating access barriers .
High procedure and maintenance costs compared to alternative modalities like electrocautery or cryotherapy
Clinical unfamiliarity and low awareness in less-developed healthcare systems
💡 Attractive Opportunities
Increasing investments in R&D and new laser technologies (more compact, software-integrated systems) offer scope for product innovation
Expansion into emerging markets as pulmonary disease burden rises and infrastructure improves .
Potential to bundle laser systems with training programs, precision diagnostics, and cost-effective treatment protocols.
📈 Market Growth & Key Expansion Factors
Market value: approx. USD 4.62 billion in 2023, rising to USD 5.06 billion in 2024 (~9.4% CAGR) .
Projections: reaching USD 7.31 billion by 2028 (~9–9.7% CAGR), and USD 6–6.7 billion in 2025 per alternate estimates
Longer‑term forecasts: market size expected to hit USD 13.2B by 2031, $19.3B by 2034, or $25.7B by 2037, depending on source—with implied CAGRs of ~11–12%.
Key Expansion Topics:
Prevalence of lung cancer and chronic respiratory illnesses fueling procedural demand
Technological advances in laser miniaturization, precision, and software-driven workflows
Growing preference for less invasive care, especially in urban and aging populations
Regulatory streamlining and integration of laser therapies into standard pulmonology care paths
🧑💼 Leading Companies
Key players operating in the Pulmonology Lasers space include:
Lumibird SA, Lumenis Ltd. (acquired by Boston Scientific), Cynosure Inc., Coherent Corp., Han’s Laser Technology, IPG Photonics, Candela Corp., Fortona, Sciton, Beijing Hoplaser, Optotek Medical, and others .
If you’d like data on company‑level revenue splits, device type shares (Nd:YAG vs photodynamic), or adoption rates by sub‑region or end‑user type, I can dive further into specific breakdowns.
Comments
Post a Comment